Jejunal Permeability – Causes, Diagnosis & Treatment

What Is Jejunal Permeability?

Jejunal permeability refers to the degree of permeability of the mucosal barrier in the jejunum, the middle section of the small intestine. The jejunum plays a central role in nutrient absorption and simultaneously acts as a barrier separating the intestinal contents from the bloodstream. The intestinal wall consists of specialized epithelial cells held together by tight junctions – protein complexes that tightly seal the gaps between adjacent cells and regulate which substances are allowed to pass through the mucosa.

Under normal conditions, nutrients, water, and electrolytes are efficiently absorbed, while pathogens, toxins, and undigested food particles are kept out. When jejunal permeability is increased – often referred to as a leaky gut of the jejunum – unwanted substances can penetrate the intestinal wall or enter the bloodstream, triggering inflammatory responses.

Structure and Function of the Jejunal Barrier

The barrier function of the jejunum is maintained by several layers:

• Mucus layer: A protective layer of mucus that traps pathogens and shields the epithelial cells.
• Epithelial cell layer: A single layer of highly specialized cells that actively transport nutrients.
• Tight junctions: Protein complexes (e.g., occludin, claudin, zonula occludens) that seal the spaces between epithelial cells.
• Immune cells of the lamina propria: An immunological surveillance layer located directly beneath the epithelium.

Because of its intense absorptive activity, the jejunum is particularly susceptible to barrier dysfunction, as its cells are exposed to high metabolic stress.

Causes of Increased Jejunal Permeability

A variety of factors can damage the intestinal barrier in the jejunum and increase its permeability:

• Inflammatory bowel diseases: Crohn's disease, celiac disease, and other enteropathies are frequently associated with disrupted jejunal permeability.
• Infections: Bacterial or viral gut infections (e.g., Salmonella, rotavirus) can damage tight junctions.
• Non-steroidal anti-inflammatory drugs (NSAIDs): Medications such as ibuprofen or diclofenac can directly damage the small intestinal mucosa.
• Malnutrition: Deficiencies in zinc, glutamine, and vitamin D impair barrier function.
• Stress and psychological burden: Via the gut-brain axis, chronic stress can weaken the epithelial barrier.
• Alcohol: Chronic alcohol consumption demonstrably increases small intestinal permeability.
• Dysbiosis: An imbalance of the gut microbiome can destabilize tight junctions.
• Radiation therapy: Abdominal irradiation can lead to radiation enteropathy with increased permeability.

Symptoms and Clinical Relevance

Increased jejunal permeability often does not cause specific symptoms but may contribute to the following complaints:

• Bloating, abdominal pain, and diarrhea
• Malabsorption of nutrients (e.g., iron, folate, calcium)
• Chronic fatigue and reduced performance
• Food intolerances
• Systemic signs of inflammation (elevated inflammatory markers in the blood)

In conditions such as celiac disease, increased jejunal permeability is a well-characterized pathophysiological feature that contributes to the autoimmune response against tissue transglutaminase.

Diagnosis

The assessment of jejunal permeability is carried out using several methods:

• Lactulose-mannitol test: The most commonly used non-invasive test. The patient drinks a solution containing lactulose (large molecule) and mannitol (small molecule). The ratio of both substances is then measured in urine. An elevated lactulose-to-mannitol ratio indicates increased permeability.
• Zonulin measurement: Zonulin is a protein that regulates the opening of tight junctions. Elevated zonulin levels in blood or stool are discussed as a marker of increased intestinal permeability, although its diagnostic validity is still scientifically debated.
• Endoscopy with biopsy: Histological examination of the jejunal mucosa can reveal structural changes in tight junctions and signs of inflammation.
• Confocal laser endomicroscopy: A more modern technique allowing real-time visualization of the mucosal barrier during endoscopy.

Treatment and Therapeutic Approaches

Treatment is directed at the underlying cause of the increased jejunal permeability:

Treatment of the Underlying Disease

In celiac disease, a strict gluten-free diet is essential for restoring the jejunal mucosa. In Crohn's disease, immunosuppressants, biologics, and anti-inflammatory medications are used.

Nutritional Therapy

• Glutamine: This amino acid is an important energy source for intestinal epithelial cells and can support barrier function.
• Zinc: Zinc plays an essential role in maintaining tight junctions.
• Probiotics: Certain bacterial strains (e.g., Lactobacillus rhamnosus GG) can strengthen the intestinal barrier.
• Prebiotics and dietary fiber: Promote a healthy gut microbiome, which in turn protects the epithelial barrier.
• Omega-3 fatty acids: Have anti-inflammatory properties and may support mucosal integrity.

Pharmacological Approaches

Research approaches include the development of substances that directly stabilize tight junctions (e.g., AT-1001/larazotide acetate in celiac disease). These agents are still being investigated in clinical trials.

Lifestyle Modification

• Stress reduction through relaxation techniques (meditation, yoga)
• Reduction of alcohol and NSAID consumption
• Adequate sleep to support intestinal mucosal regeneration

References

1. Camilleri M. et al. - Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterology and Motility, 2012.
2. Fasano A. - Leaky gut and autoimmune diseases. Clinical Reviews in Allergy and Immunology, 2012; 42(1): 71-78.
3. World Gastroenterology Organisation (WGO) - Practice Guidelines: Celiac Disease, 2016. Available at: www.worldgastroenterology.org